| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8662474 | International Journal of Cardiology | 2018 | 27 Pages |
Abstract
Our preliminary results suggest that in individuals with He-FH, a 3-month treatment period with rosuvastatin determines a significant reduction in arterial stiffness, possibly through its pleiotropic vascular effect beyond lowering of plasma cholesterol.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Marco Canepa, Nathan Artom, Pietro Ameri, Federico Carbone, Fabrizio Montecucco, Giorgio Ghigliotti, Claudio Brunelli, Franco Dallegri, Aldo Pende, Livia Pisciotta,